Cancer treatment breakthrough: ‘Nanodots’ kill tumours, sparing healthy cells
Nanodots are made from widely used metal oxide, offering a more affordable and safer option
The researchers in a recent breakthrough have discovered a revolutionary cancer treatment in which healthy cells would be largely unharmed.
Scientists belonging to RMIT University have developed cancer-destroying very small particles called “nanodots” which can destroy cancerous cells while protecting the healthy cells.
Made from molybdenum oxide, these nanoparticles release reactive oxygen molecules. These unstable molecules can push cancer cells into apoptosis, programmed cell death, as reported by study's lead researchers Professor Jian Zhen Ou and Dr. Baoyue Zhang.
During the experimental stage, these nanodots show high efficiency in killing cervical cancer cells at three times the rate of healthy cells over 24 hours.
“Cancer cells already live under higher stress than healthy ones. Our particles push that stress a little further -- enough to trigger self-destruction in cancer cells, while healthy cells cope just fine,” Zhang said.
The recent experiment offers key advantages over existing cancer treatments. The existing cancer therapies damage healthy body cells along with tumors. Unlike the light-required therapies, the nanodots can work effectively in complete darkness as well.
Moreover, Nanodots are made from widely used metal oxide, so they offer a more affordable and safer option.
The research study involves a global collaboration between The Florey Institute of Neuroscience and Mental Health (Melbourne) and several institutions in China (Southeast, Hong Kong Baptist, and Xidian Universities).
The research is in its early stages as it has only been tested to lab-grown cells. It has not yet been tested on animals or humans.
-
What to know before using weight-loss drugs like Ozempic
-
Singapore confirms first local spread of mutated monkeypox clade Ib strain
-
World Autism Awareness Day: Celebrating different minds, shaping a shared future
-
Some grief never goes away—Scientists now know why
-
E-cigarettes: A proving quitting tool that still carries health risks
-
Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine
-
London sewage detects polio weeks after funding drop
-
COVID-19 ‘Cicada’ variant: Here’s everything to know
-
Eye drops made from pig body fluid could revolutionize cancer treatment, new study says
-
Paul Conyngham uses ChatGPT, AlphaFold to develop a life-saving cancer vaccine for his dog
-
'Cicada' COVID variant detected in multiple countries as experts study mutation risks
-
Metformin’s hidden brain pathway uncovered after 60 years
